Lu Zhang

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

C.E.M. Griffiths, Kristian Reich, Mark Lebwohl et al. · The Lancet · 2015 · 815 citations

Randomised Trials, Clinical Trials, Clinical Dermatology +5

A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia

AnnCatherine M. Downing, Bruce J. Kinon, Brian A. Millen et al. · BMC Psychiatry · 2014 · 113 citations · Full text

Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)

Andrew Blauvelt, Melinda Gooderham, Lars Iversen et al. · Journal of the American Academy of Dermatology · 2017 · 111 citations · Full text

Pomaglumetad Methionil (LY2140023 Monohydrate) and Aripiprazole in Patients with Schizophrenia: A Phase 3, Multicenter, Double-Blind Comparison

David H. Adams, Lu Zhang, Brian A. Millen et al. · Schizophrenia Research and Treatment · 2014 · 75 citations · Full text

Psychotropic Medication, Psychopharmacology, Pomaglumetad Methionil +19

Equivalence of critical and subcritical sharp Trudinger–Moser–Adams inequalities

Nguyen Lam, Guozhen Lu, Lu Zhang · Revista Matemática Iberoamericana · 2017 · 73 citations · Full text

Spectral Theory, Elliptic Equation, Engineering +8